Stanford University's Dr. Sharon Sha presented findings on November 4, 2017. Her clinical trial found that administering blood plasma from young donors to people with mild to moderate Alzheimer's disease was safe.
Plasma has been in continuous use since 1918.
The United States infuses 4 million units of plasma each year.